A murine model of Cryptococcus gattii meningoencephalitis

George Richard Thompson, Nathan P. Wiederhold, Laura K. Najvar, Rosie Bocanegra, William R. Kirkpatrick, John R. Graybill, Thomas F. Patterson

Research output: Contribution to journalArticle

20 Citations (Scopus)

Abstract

Objectives: Meningoencephalitis caused by Cryptococcus gattii is associated with significant morbidity and the need for aggressive therapy, and often necessitates neurosurgical intervention. We adapted a previously described murine model of cryptococcal meningoencephalitis due to Cryptococcus neoformans to that caused by C. gattii. Methods: Mice were inoculated intracranially with either C. gattii (genotype VGIIa) or C. neoformans. In virulence studies, different C. gattii infecting inocula were compared with a fixed inoculum of C. neoformans, and differences were assessed by survival, brain tissue fungal burden, serum antigen titres and histopathological changes within brain tissue. For treatment, fluconazole or posaconazole (10 mg/kg orally twice daily) was initiated 24 h post-inoculation. Results: C. gattii was more virulent than C. neoformans, as evident by shorter median survival, earlier histopathological changes and higher serum antigen titres. However, no differences in fungal burden or dissemination to other organs were observed among the various groups. In treatment studies, both fluconazole and posaconazole improved the median survival of mice infected with either species. However, neither regimen improved the percentage of animals surviving to the predetermined study endpoint. Conclusions: These results demonstrate the virulence of C. gattii meningoencephalitis and the potential of this model for the assessment of new treatment strategies.

Original languageEnglish (US)
Article numberdks060
Pages (from-to)1432-1438
Number of pages7
JournalJournal of Antimicrobial Chemotherapy
Volume67
Issue number6
DOIs
StatePublished - Jun 2012

Fingerprint

Cryptococcus gattii
Meningoencephalitis
Cryptococcus neoformans
Fluconazole
Virulence
Antigens
Tissue Survival
Brain
Serum
Genotype
Morbidity

Keywords

  • C. gattii
  • Cryptococcal meningoencephalitis
  • Cryptococcus neoformans
  • Fluconazole
  • Posaconazole

ASJC Scopus subject areas

  • Pharmacology
  • Pharmacology (medical)
  • Infectious Diseases

Cite this

Thompson, G. R., Wiederhold, N. P., Najvar, L. K., Bocanegra, R., Kirkpatrick, W. R., Graybill, J. R., & Patterson, T. F. (2012). A murine model of Cryptococcus gattii meningoencephalitis. Journal of Antimicrobial Chemotherapy, 67(6), 1432-1438. [dks060]. https://doi.org/10.1093/jac/dks060

A murine model of Cryptococcus gattii meningoencephalitis. / Thompson, George Richard; Wiederhold, Nathan P.; Najvar, Laura K.; Bocanegra, Rosie; Kirkpatrick, William R.; Graybill, John R.; Patterson, Thomas F.

In: Journal of Antimicrobial Chemotherapy, Vol. 67, No. 6, dks060, 06.2012, p. 1432-1438.

Research output: Contribution to journalArticle

Thompson, GR, Wiederhold, NP, Najvar, LK, Bocanegra, R, Kirkpatrick, WR, Graybill, JR & Patterson, TF 2012, 'A murine model of Cryptococcus gattii meningoencephalitis', Journal of Antimicrobial Chemotherapy, vol. 67, no. 6, dks060, pp. 1432-1438. https://doi.org/10.1093/jac/dks060
Thompson GR, Wiederhold NP, Najvar LK, Bocanegra R, Kirkpatrick WR, Graybill JR et al. A murine model of Cryptococcus gattii meningoencephalitis. Journal of Antimicrobial Chemotherapy. 2012 Jun;67(6):1432-1438. dks060. https://doi.org/10.1093/jac/dks060
Thompson, George Richard ; Wiederhold, Nathan P. ; Najvar, Laura K. ; Bocanegra, Rosie ; Kirkpatrick, William R. ; Graybill, John R. ; Patterson, Thomas F. / A murine model of Cryptococcus gattii meningoencephalitis. In: Journal of Antimicrobial Chemotherapy. 2012 ; Vol. 67, No. 6. pp. 1432-1438.
@article{74794b2066b248c2a6be34ba1c836301,
title = "A murine model of Cryptococcus gattii meningoencephalitis",
abstract = "Objectives: Meningoencephalitis caused by Cryptococcus gattii is associated with significant morbidity and the need for aggressive therapy, and often necessitates neurosurgical intervention. We adapted a previously described murine model of cryptococcal meningoencephalitis due to Cryptococcus neoformans to that caused by C. gattii. Methods: Mice were inoculated intracranially with either C. gattii (genotype VGIIa) or C. neoformans. In virulence studies, different C. gattii infecting inocula were compared with a fixed inoculum of C. neoformans, and differences were assessed by survival, brain tissue fungal burden, serum antigen titres and histopathological changes within brain tissue. For treatment, fluconazole or posaconazole (10 mg/kg orally twice daily) was initiated 24 h post-inoculation. Results: C. gattii was more virulent than C. neoformans, as evident by shorter median survival, earlier histopathological changes and higher serum antigen titres. However, no differences in fungal burden or dissemination to other organs were observed among the various groups. In treatment studies, both fluconazole and posaconazole improved the median survival of mice infected with either species. However, neither regimen improved the percentage of animals surviving to the predetermined study endpoint. Conclusions: These results demonstrate the virulence of C. gattii meningoencephalitis and the potential of this model for the assessment of new treatment strategies.",
keywords = "C. gattii, Cryptococcal meningoencephalitis, Cryptococcus neoformans, Fluconazole, Posaconazole",
author = "Thompson, {George Richard} and Wiederhold, {Nathan P.} and Najvar, {Laura K.} and Rosie Bocanegra and Kirkpatrick, {William R.} and Graybill, {John R.} and Patterson, {Thomas F.}",
year = "2012",
month = "6",
doi = "10.1093/jac/dks060",
language = "English (US)",
volume = "67",
pages = "1432--1438",
journal = "Journal of Antimicrobial Chemotherapy",
issn = "0305-7453",
publisher = "Oxford University Press",
number = "6",

}

TY - JOUR

T1 - A murine model of Cryptococcus gattii meningoencephalitis

AU - Thompson, George Richard

AU - Wiederhold, Nathan P.

AU - Najvar, Laura K.

AU - Bocanegra, Rosie

AU - Kirkpatrick, William R.

AU - Graybill, John R.

AU - Patterson, Thomas F.

PY - 2012/6

Y1 - 2012/6

N2 - Objectives: Meningoencephalitis caused by Cryptococcus gattii is associated with significant morbidity and the need for aggressive therapy, and often necessitates neurosurgical intervention. We adapted a previously described murine model of cryptococcal meningoencephalitis due to Cryptococcus neoformans to that caused by C. gattii. Methods: Mice were inoculated intracranially with either C. gattii (genotype VGIIa) or C. neoformans. In virulence studies, different C. gattii infecting inocula were compared with a fixed inoculum of C. neoformans, and differences were assessed by survival, brain tissue fungal burden, serum antigen titres and histopathological changes within brain tissue. For treatment, fluconazole or posaconazole (10 mg/kg orally twice daily) was initiated 24 h post-inoculation. Results: C. gattii was more virulent than C. neoformans, as evident by shorter median survival, earlier histopathological changes and higher serum antigen titres. However, no differences in fungal burden or dissemination to other organs were observed among the various groups. In treatment studies, both fluconazole and posaconazole improved the median survival of mice infected with either species. However, neither regimen improved the percentage of animals surviving to the predetermined study endpoint. Conclusions: These results demonstrate the virulence of C. gattii meningoencephalitis and the potential of this model for the assessment of new treatment strategies.

AB - Objectives: Meningoencephalitis caused by Cryptococcus gattii is associated with significant morbidity and the need for aggressive therapy, and often necessitates neurosurgical intervention. We adapted a previously described murine model of cryptococcal meningoencephalitis due to Cryptococcus neoformans to that caused by C. gattii. Methods: Mice were inoculated intracranially with either C. gattii (genotype VGIIa) or C. neoformans. In virulence studies, different C. gattii infecting inocula were compared with a fixed inoculum of C. neoformans, and differences were assessed by survival, brain tissue fungal burden, serum antigen titres and histopathological changes within brain tissue. For treatment, fluconazole or posaconazole (10 mg/kg orally twice daily) was initiated 24 h post-inoculation. Results: C. gattii was more virulent than C. neoformans, as evident by shorter median survival, earlier histopathological changes and higher serum antigen titres. However, no differences in fungal burden or dissemination to other organs were observed among the various groups. In treatment studies, both fluconazole and posaconazole improved the median survival of mice infected with either species. However, neither regimen improved the percentage of animals surviving to the predetermined study endpoint. Conclusions: These results demonstrate the virulence of C. gattii meningoencephalitis and the potential of this model for the assessment of new treatment strategies.

KW - C. gattii

KW - Cryptococcal meningoencephalitis

KW - Cryptococcus neoformans

KW - Fluconazole

KW - Posaconazole

UR - http://www.scopus.com/inward/record.url?scp=84861108451&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84861108451&partnerID=8YFLogxK

U2 - 10.1093/jac/dks060

DO - 10.1093/jac/dks060

M3 - Article

VL - 67

SP - 1432

EP - 1438

JO - Journal of Antimicrobial Chemotherapy

JF - Journal of Antimicrobial Chemotherapy

SN - 0305-7453

IS - 6

M1 - dks060

ER -